Come join us at the Drug Discovery & Development of Innovative Therapeutics Conference on August 6th !!
Pharma Connections Worldwide will be hosting a business networking event on Wednesday August 6th, 5:30-7:30PM at Anthony’s Pier4 Restaurant, within walking distance of the IBC USA Event. To RSVP, please respond to registration@pharmaconnections.com
————————————————————————
Drug Discovery & Development of Innovative Therapeutics Conference
August 4-7, 2008
World Trade Center Boston & Seaport Hotel
Boston, MA
Register by June 20th
and Save $200
Drug Discovery & Development of Innovative Therapeutics is the ONE conference that continues, year after year, to bring together cutting edge scientists, leading academia, and the world’s top drug discovery and development experts - all in one place, at one time.
Download the agenda-at-a-glance
View full conference agenda online
View the speaker list online
Just announced June 1, 2008:
NIH to fund $500+ billion in Translational Research
Attend this event and learn the state of the art in translational research techniques across multiple therapeutic areas. View the Translational Medicine sessions in the online agenda.
Register by June 20 Using Priority Code DQYTJRC and Save $200
Pre-schedule Meetings with Other Attendees Using our Online Partnering Tool
Call for Posters - Come Share Your Research Findings. Submission deadline is July 16.
For more information visit www.drugdisc.com
or call 800-390-4078.
Mobile (www.pharmaconnections.mobi)
Astra Zeneca News- AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR®
- Second Quarter and Half Year Results 2008
- AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes
- Summary Judgment Granted for SEROQUEL Patent Litigation in the US
- AstraZeneca Announces Senior Management Changes at Biologics Business Unit, MedImmune
- AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration to Develop Novel Therapeutics for Diabetes and Obesity
- AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of Major Depressive Disorder
- AstraZeneca Submits an sNDA for SYMBICORT® for the Treatment of Asthma in Children as Young as Age Six
- Genome Web
- Scripps to use RainDance Technology in 'Wellderly' Study
- NSF Grants $1.3M to Study Oklahoma Sulfur Spring Microbes
- Karolinska and Collaborators to Team 'Omics, Imaging in New Cancer Studies
- OncoMethylome's First-Half '08 Sales Rise 35 Percent
- Monsanto, Evogene Enter Into R&D Collaboration
- AnaSpec Licenses Protein Tyrosine Phosphate IP from UW TechTransfer
- FDA Wants to Talk with LabCorp Regarding Ovarian Cancer IVDMIA
- Tepnel Gets CE Mark for DNA-Based Cholesterol Test
- Source BioScience's First-Half '08 Revenues Jump 88 Percent
- MicroRNA Methylation Linked to Cancer Metastasis
- BioPharm International
- Global Biochemical Profiling for Bioprocessing Optimization
- Final Bulk Inspection of Solid-Dose Pharmaceuticals
- Chemists Developing Fully-Synthetic Form of Heparin
- Genentech Rejects Roche Proposal
- Bridge Laboratories to Build Second Facility in Beijing
- Florida Biologix Signs cGMP Agreement with National Taiwan University Hopsital
- Denny Kraichely Joins Editorial Advisory Board of BioPharm International
- FDA Issues Six Draft Guidance Documents
- Determining Critical Quality Attributes Forms the Foundation for QbD Implementation
- Gail Sofer, BioPharm EAB Member, Retires from GE
- Applied Clinical Trials
- IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs
- ProTrials Makes The Inc. 5000, Reflecting Three-Year Sales Growth
- Parexel Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
- Foundation Formed to Improve Data Quality in Clinical Trials
- Dutch company Factory CRO chooses US-based AmeriStart
- MedNet Included on INC 5000 List
- Covance and Lilly Reach Strategic Agreement
- Parexel Closes The Acquisition Of Clinphone
- Good Products Launches ValMan to Facilitate Validation Project Management
- Omnicare Clinical Research Opens Office In Sweden
- Pharma-Careers Job Listings
- BioCompare Events
- Maintenance of Genome Stability Conference 2010
- Stem Cells 2009
- Chromatin: Structure & Function Conference 2009
- Synaptic Inhibition in Health and Disease conference
- American Society of Human Genetics 59th Annual Meeting
- 23rd Annual Symposium of The Protein Society
- Apoptosis and Cancer: The Bcl-2 family of proteins
- Chromatin, Replication and Chromosomal Stability conference
- Merck Research News
- Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV™) Met its Primary Endpoint
- Merck's Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study
- Schering-Plough And Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
- PharmaLicensing Opportunities
- NCE's - Small molecules indicated for inflammation/autoimmune disorders
- Inflammation/autoimmune commercialized drugs
- UR-1505: Immunomodulator, Phase II
- Desalazine: Anti-inflammatory agent, Phase I
- L-histidine as an anti-oxidant, neuroprotective agent, and medical food
- Neoskin®: for skin and mucous wound healing - 1x5ml tube
- Apharine®: for the treatment of oral ulcers-2x2 ml re plugable ampoules
- Prostagenics offers license for all Capridines, including Capridine-Beta.
- Xconomy Life Sciences
- SonoSite Marketing Boss Resigns to Take Job at Smith & Nephew
- Dendreon Rival Suffers Meltdown, Investors Sitting Tight For Next Big Clinical Trial News
- Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
- After Cutting Deals With Most of the Big Drug Cos, Sermo CEO Offers Health 2.0 Survival Tip: You Will Not Pay Your Bills with “Ads by Google”
- Ultrasound Stethoscopes, Stealthy Software, A New Enzyme Startup, and More from Alexandria Real Estate’s Summer Celebration
- Salient Surgical Cuts $86M IPO
- Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis
- UW TechTransfer’s Linden Rhoads Aiming to Nurture More Startups, Entice More VCs to Look at UW’s Research Cupboard
- PharmaEdge Blog
- Thomson - Reuters Science News
- Gustav kills 59 in Caribbean, aims at U.S
- Canada wants more study on polar bear protection
- Why it's so hard to swat a fly
- Scientists find ancient lost settlements in Amazon
- Colliding galaxies shed light on dark matter
- Researchers turn living cells into insulin-makers
- Dead Sea Scrolls to go digital on Internet
- "Grease to Greece" racers cross Europe on cooking oil
Pages
You must be logged in to post a comment.